Recruiting UTI Studies in New Haven
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric Patients
This is a multicenter, randomized, double-blind, placebo-controlled study in pediatric patients aged 5 to 17 years with a primary diagnosis of irritability associated with Autism Spectrum Disorder (AS...
ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD)
ML-004-002 is a multi-center, randomized, double-blind, parallel-group, placebo-controlled study that will enroll approximately 150 adolescent and adult subjects with ASD. The primary objective is to ...
About UTI Clinical Trials in New Haven
Urinary tract infections (UTIs) are infections in any part of the urinary system, most commonly the bladder and urethra. They are among the most common bacterial infections. Treatment typically involves antibiotics, with research focusing on prevention strategies and antibiotic resistance.
There are currently 2 uti clinical trials recruiting participants in New Haven, CONNECTICUT. These studies are seeking a combined 324 participants. Research is being sponsored by Intra-Cellular Therapies, Inc., MapLight Therapeutics. Clinical trial participation is free and participants receive study-related medical care at no cost.
UTI Clinical Trials in New Haven — FAQ
Are there uti clinical trials in New Haven?
Yes, there are 2 uti clinical trials currently recruiting in New Haven, CONNECTICUT. Browse the studies on this page to find one that fits.
How do I join a clinical trial in New Haven?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Haven research site will contact you about next steps.
Are clinical trials in New Haven free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Haven studies also compensate for your time and travel.
What uti treatments are being tested?
The 2 active trials in New Haven are testing new therapies including novel drugs, biologics, and treatment approaches for uti.
Data updated March 2, 2026 from ClinicalTrials.gov